http://www.generex.com/Developed a proprietary technology to administer large molecule drugs, including hormone proteins, peptides, monoclonal antibodies and vaccines as a mist absorbed in the buccal mucosa. Overview of production, aims and investor data of company in Toronto, Ontario.Biopharmaceuticals > Delivery SystemsGenerex Biotechnology Corporation
Wednesday, March 30, 2011
Wednesday, March 30, 2011 16:30:00
Wednesday, March 30, 2011 13:00:00
Thursday, October 21, 2010 13:00:00
Tuesday, October 12, 2010 10:00:00
Generex Biotechnology Corporation is engaged in the research, development, and commercialization of drug delivery systems andGenerex Biotechnology Corporation
Developed a proprietary technology to administer large molecule drugs, including hormone proteins, peptides, monoclonal antibodies and vaccines as a mist absorbed in the buccal mucosa. Overview of production, aims and investor data of company in Toronto, Ontario.
Manufactures custom peptides, protein conjugates and liposomes. Includes technology overview, applications, request forms and contacts in North West England.
Non-viral drug delivery technology based on cationic liposomes, under clinical development for vector systems on license from Imperial College, London, UK.
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.